SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,515.43 362.57
( 0.48%)

Global Indices

Nasdaq

53,682.77 599.82
(1.13%)

Dow Jones

7,765.55 77.95
(1.01%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,831.87 75.42
(0.70%)

Forex

USD-INR

94.73 -0.22
(-0.23%)

EUR-INR

109.71 -0.40
(-0.36%)

GBP-INR

127.83 -0.65
(-0.50%)

JPY-INR

0.59 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Curis Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

94348

INE1BZN01016

58.5748291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CURIS

16.93

117.31

EPS(TTM)

Face Value()

Div & Yield %

8.57

Back

HB Portfolio consolidated net profit rises 158.26% in the June 2026 quarter

Aug 10,2026

Net profit of HB Portfolio rose 158.26% to Rs 5.63 crore in the quarter ended June 2026 as against Rs 2.18 crore during the previous quarter ended June 2025. Sales rose 34.55% to Rs 10.36 crore in the quarter ended June 2026 as against Rs 7.70 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	10.36	7.70	35
OPM %	59.94	46.88	-
PBDT	6.30	3.64	73
PBT	6.11	3.43	78
NP	5.63	2.18	158

76,515.43 362.57 ( 0.48%)

53,682.77 599.82 (1.13%)

7,765.55 77.95 (1.01%)

65,002.68 788.20 (1.23%)

10,831.87 75.42 (0.70%)

94.73 -0.22 (-0.23%)

109.71 -0.40 (-0.36%)

127.83 -0.65 (-0.50%)

0.59 0.00 (0.14%)